Summarized by Masters of Longevity from FDA - Press Releases.
This article previews a news report about a newly approved generic once-weekly hormone therapy patch for women with a uterus, explaining what readers can expect to learn about the treatment option and its use.
Key Takeaways
- The FDA approved the first generic of a once-weekly estradiol and levonorgestrel patch.
- The approved generic delivers 0.045 mg estradiol and 0.015 mg levonorgestrel per day.
- The patch is indicated for hormone therapy in women with an intact uterus and applied weekly.
